Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 4: ISV Annual Congress
Submit an article Journal homepage
1,777
Views
1
CrossRef citations to date
0
Altmetric
ISV Annual Congress SF – Article Commentary

Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production

Anup Dattaa Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USAView further author information
,
Kapil Kaprea Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA;b Process Automation & Support, Inventprise, Inc., Redmond, WA, USAView further author information
,
Indah Andi-Loloa Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA;c Portfolio Management, Inventprise, Inc., Redmond, WA, USACorrespondence[email protected]
View further author information
&
Subhash Kaprea Bacterial Vaccine R&D, Inventprise, Inc., Redmond, WA, USA;d Founder Chairman, Inventprise, Inc., Redmond, WA, USAView further author information
Article: 2117949 | Received 06 Jul 2022, Accepted 22 Aug 2022, Published online: 14 Oct 2022

References

  • World Health Organizations (WHO). Children: improving survival and well-being. https://www.who.int/news-room/fact-sheets/detail/children-reducing-mortality
  • O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, et al.; Hib and PneumococcalGlobal Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet Lond Engl. 2009;374(9693):1–5. doi:10.1016/S0140-6736(09)61204-6.
  • Graham H, Bakare AA, Fashanu C, Wiwa O, Duke T, Falade AG. Oxygen; 2020
  • Center for Disease Control and Prevention (CDC). Global pneumococcal disease and vaccine; 2021. https://www.cdc.gov/pneumococcal/global.html
  • Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, et al. The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance. Vaccine. 2013;31:B61–B72. doi:10.1016/j.vaccine.2012.11.035.
  • Huang Q, Li D, Kang A, An W, Fan B, Ma X, Ma G, Su Z, Hu T. PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine. J Control Release. 2013;172(1):382–389f. doi:10.1016/j.jconrel.2013.03.008.
  • Alderson MR, LaForce FM, Sobanjo-Ter Meulen A, Hwang A, Preziosi M-P, Klugman KP. Eliminating meningococcal epidemics from the African meningitis belt: the case for advanced prevention and control using next-generation meningococcal conjugate vaccines. J Infect Dis. 2019;220(Suppl 4):S274–S278. doi:10.1093/infdis/jiz297.
  • Dagan R, Poolman J, Siegrist C-A. Glycoconjugate vaccines and immune interference: a review. Vaccine. 2010;28(34):5513–5523. doi:10.1016/j.vaccine.2010.06.026.
  • Varghese J, Chochua S, Tran T, Walker H, Li Z, Snippes Vagnone PM, Lynfield R, McGee L, Li Y, Metcalf BJ. Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017. Clin Microbiol Infect. 2020 Apr;26(4): 512.e1-512.e10. doi:10.1016/j.cmi.2019.09.008.
  • https://atlas.ecdc.europa.eu/public/index.aspx?Dataset=27&HealthTopic=40

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.